Savarese, Gianluigi
 Distribuzione geografica
Continente #
AS - Asia 725
NA - Nord America 398
EU - Europa 284
SA - Sud America 220
AF - Africa 13
Totale 1.640
Nazione #
US - Stati Uniti d'America 375
SG - Singapore 291
BR - Brasile 200
HK - Hong Kong 145
CN - Cina 138
IT - Italia 89
VN - Vietnam 51
DE - Germania 36
RU - Federazione Russa 36
TR - Turchia 31
FI - Finlandia 27
GB - Regno Unito 20
CA - Canada 14
ES - Italia 12
IN - India 12
NL - Olanda 12
AT - Austria 11
BD - Bangladesh 11
IQ - Iraq 11
FR - Francia 9
AR - Argentina 8
UA - Ucraina 8
PL - Polonia 7
SA - Arabia Saudita 6
JP - Giappone 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
LT - Lituania 4
PK - Pakistan 4
SE - Svezia 4
VE - Venezuela 4
ZA - Sudafrica 4
CO - Colombia 3
EC - Ecuador 3
MX - Messico 3
UZ - Uzbekistan 3
CR - Costa Rica 2
ID - Indonesia 2
IR - Iran 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MM - Myanmar 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 1.640
Città #
Hong Kong 145
Singapore 114
Beijing 64
Ashburn 49
Los Angeles 29
Istanbul 26
Dallas 22
São Paulo 22
Ho Chi Minh City 21
The Dalles 19
Moscow 17
Romola 17
New York 16
Buffalo 15
Munich 15
Lappeenranta 14
Redondo Beach 13
San Francisco 12
Hanoi 11
Nuremberg 9
Rome 9
Santa Clara 9
Chicago 8
Milan 8
Atlanta 7
Montreal 7
Rio de Janeiro 7
Shanghai 7
Belo Horizonte 6
Helsinki 6
Turku 6
Warsaw 6
Baghdad 5
Brasília 5
Brooklyn 5
Charlotte 5
Chennai 5
Denver 5
Turin 5
Amsterdam 4
Boston 4
Da Nang 4
Erbil 4
Frankfurt am Main 4
London 4
Stockholm 4
Tokyo 4
Vienna 4
West Jordan 4
Airola 3
Bari 3
Boardman 3
Caracas 3
Contagem 3
Dhaka 3
Guangzhou 3
Itajaí 3
Manaus 3
Naples 3
Orem 3
Piracicaba 3
Pittsburgh 3
Porto Alegre 3
Potsdam 3
Salvador 3
Serra 3
Sorocaba 3
São Bernardo do Campo 3
Tashkent 3
Toronto 3
A Coruña 2
Angra dos Reis 2
Ankara 2
Araruama 2
Bagnoli del Trigno 2
Bernareggio 2
Brescia 2
Campinas 2
Carapicuíba 2
Caravaggio 2
Clorinda 2
Dubai 2
Duhok 2
Düsseldorf 2
Farroupilha 2
Feira de Santana 2
Fortaleza 2
Genoa 2
Goiânia 2
Haiphong 2
Jeddah 2
Johannesburg 2
Lahore 2
Leno 2
Livorno 2
Lleida 2
Logroño 2
Macapá 2
Madrid 2
Makhachkala 2
Totale 934
Nome #
2024 update in heart failure 81
Sodium glucose co-transporter 2 inhibitors and quality of life in patients with heart failure: a comprehensive systematic review and meta-analysis of randomized controlled trials 66
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 61
How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC 59
Diagnosis and Management of Patients with Left Ventricular Hypertrophy: Role of Multimodality Cardiac Imaging. A Scientific Statement of the Heart Failure Association of the ESC 58
OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM-HF registry 57
GLP-1-ra and heart failure-related outcomes in patients with and without history of heart failure: an updated systematic review and meta-analysis 54
Association between a hospitalization for heart failure and the initiation/discontinuation of guideline-recommended treatments: an analysis from the Swedish Heart Failure Registry 52
Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta-analysis 52
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension 52
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies 51
Comprehensive Characterization of Non-Cardiac Comorbidities in Acute Heart Failure- an analysis of ESC-HFA EORP Heart Failure Long-Term Registry 51
Efficacy of SGLT2-inhibitors across different definitions of heart failure with preserved ejection fraction 49
Multidisciplinary care of peripartum heart failure: A scientific statement of the Heart Failure Association of the ESC 48
Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry 47
Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC 47
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology 46
Epidemiology, pathophysiology, diagnosis and management of chronic right-sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC 45
Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: an analysis from the HELP-HF registry 45
Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry 45
Glucagon-like peptide-1 receptor agonists use and associations with outcomes in heart failure and type 2 diabetes. Data from the Swedish Heart Failure and Swedish National Diabetes Registries 44
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology (ESC) 41
The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry 41
Prevalence, Characteristics and Prognostic Impact of Aortic Valve Disease in Patients with Heart Failure and Reduced, Mildly Reduced, and Preserved Ejection Fraction: An Analysis of the ESC Heart Failure Long-Term Registry 41
Insights into the European heart failure epidemiology 41
Rationale and Design of the ESC Heart Failure III Registry - Implementation and Discovery 40
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) 39
Interaction of Heart Failure and Stroke: A clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis 38
Physician perceptions, attitudes, and strategies towards implementing guideline-directed medical therapy in heart failure with reduced ejection fraction. A survey of the Heart Failure Association of the ESC and the ESC Council for Cardiology Practice 37
Cardiac resynchronization therapy for enabling guideline-directed medical therapy optimization in heart failure 36
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 36
Prevalence, clinical characteristics and outcomes of heart failure patients with or without isolated or combined mitral and tricuspid regurgitation: insight from the ESC-HFA EORP Heart Failure Long-Term Registry 36
Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC 31
Translating the 2021 ESC heart failure guideline recommendations in daily practice: Results from a heart failure survey. A scientific statement of the ESC Council for Cardiology Practice and the Heart Failure Association of the ESC 30
Evidence Generation and Implementation of Transcatheter Interventions for Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and Future Directions 28
Awareness, access, and adoption of natriuretic peptides for diagnosis of heart failure 26
Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC 26
Totale 1.677
Categoria #
all - tutte 10.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20235 0 0 0 0 0 0 0 0 0 0 0 5
2023/2024195 3 8 4 7 16 2 11 8 46 10 38 42
2024/2025590 9 2 25 70 49 37 79 15 52 40 114 98
2025/2026887 215 197 117 203 139 16 0 0 0 0 0 0
Totale 1.677